AN2 Therapeutics, Inc.
corporate_fare Company Profile
AN2 Therapeutics, Inc. (NASDAQ:ANTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ANTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- AN2 Therapeutics Appoints New Principal Accounting Officer, Reduces CFO Compensation Amid Cost-Savings
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$35.17M
Diluted EPS
-$1.16
Op. Cash Flow
-$29.83M
Operating Income
-$38.11M
Cash & Equivalents
$19.94M
Debt / Equity
0.00×
Shares Outstanding
27.41M sh
Source: 10-K · filed 2026-03-17 · accession 0001193125-26-110693
show_chartPrice Chart
Loading chart...
feed ANTX - Filings & News (Page 2)
ANTX
Jan 29, 2026, 4:45 PM EST
Price at Filing:
$1.13
Real-time Price:
$5.08
Change:
+$3.95 (+350%)
Market Cap:
$192.754M